CoChat

Guideline for Male Testosterone Therapy: A European Perspective

Wu, Frederick C. W. · 2007 · The Journal of Clinical Endocrinology & Metabolism
Cited by 18

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Why are we suddenly assailed with a plethora of guidelines for testosterone (T) therapy in androgen deficiency (1–3), a condition that has been managed with relative success and apparent patient satisfaction for nearly seven decades? Prescriptions for T in the United States have increased by 400% since 1999 (4), mainly in middle-aged men. Interestingly, this trend has not been duplicated in Europe [Intercontinental Marketing Services (IMS) Health Inc., New York, unpublished data] or Australasia (5). Has there been an epidemic of male hypogonadism in North America, or does this reflect a substantial shift in approach to the diagnosis and treatment of androgen deficiency? The age-related decline in T (6) in an increasing elderly male population is the likely drive behind this trend, fueled by a number of factors specific to the United States. These include direct-to-patient pharmaceutical advertising, ready availability of reimbursement by health-care providers, willingness of patients to pay for prescriptions, prevalence of an antiageing ethos, and, most importantly, clinicians’ attitude in accepting perceived novel therapeutic opportunities. The use of T in men with chronic illnesses is still underappreciated and is unlikely to have contributed substantially to the prescribing increase.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2006-2799

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Wu, F. C. W.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2007-02-01
Volume
92
Issue
2
Pages
418-419
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2129151372
Cited by
18
References
4
FWCI
1.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.